Pluripotent stem cell for treating diabetic skin ulcer

Abstract

The purpose of the present invention is to provide a novel medicinal use in regeneration medicine, said medicinal use comprising using pluripotent stem cells (Muse cells). Provided is a cell preparation for treating skin ulcer, said cell preparation comprising SSEA-3 positive pluripotent stem cells isolated from a mesenchymal tissue of a living organism or cultured mesenchymal cells. The cell preparation according to the present invention is based on such mechanism of skin tissue regeneration that, when the Muse cells are administered to a skin ulcer site of a subject suffering from the aforesaid disease, the Muse cells differentiate into skin-constituting cells.

Description

TECHNICAL FIELD[0001]The present invention relates to a cell preparation for use in regenerative medicine. More particularly, the present invention relates to a cell preparation comprising pluripotent stem cells effective for repair and regeneration of skin tissue in skin ulcers including skin ulcers caused by diabetes, and to a method for treating skin ulcers that uses these pluripotent stem cells.BACKGROUND ART[0002]Diabetes is a disease that is associated with persistent hyperglycemic state and is said to occur as a result of the actions of a diverse range of environmental and genetic factors. The main regulatory factor of blood sugar is insulin, and hyperglycemia is known to occur due to insulin deficiency or an excess of factors that inhibit the action thereof (such as genetic predisposition, lack of exercise, obesity or stress). Diabetes is classified as type 1 diabetes, which occurs primarily due to a decrease in pancreatic insulin secretory function attributable to such fact...

AI Technical Summary

Benefits of technology

The invention uses a method to treat skin ulcers by giving a specific type of cell (Muse cells) to the sore area. These cells are able to turn into different types of cells that make up skin tissue, helping to heal the ulcer and restore skin function.

Problems solved by technology

In Japan, diabetes has become a modern-day national affliction and more than 95% of diabetes patients (which is estimated to exceed 20 million people when including persons at risk to the onset of diabetes) have been diagnosed with non-insulin-dependent diabetes mellitus, and increases in the number of patients is becoming a problem accompanying lifestyle changes.

Many serious complications of diabetes such as heart disease, kidney failure or blindness have an effect on individuals together with diabetes, and complications involving the lower extremities result in the greatest damage.

Patients afflicted with diabetes mellitus are at greater risk to the onset of chronic skin ulcers such as ulcers of the leg and foot accompanying long-term complications.

However, in cases in which microvascular disease (or ischemia) is present, this response is significantly impaired, and this is considered to most likely be important in the etiology of ulcers together with a tendency towards the occurrence of thrombosis in the microcirculation during reduced blood flow.

On the other hand, nerve disorders lack an adequately established treatment method with respect to both the symptomatic treatment thereof and the prevention of the progressive decline of nerve function, and is one of the major complications of diabetes mellitus.

The effects of peripheral nerve disorders are particularly complex.

However, these attempts have not led to complete recovery at the injured site.

In addition, although mesenchymal stem cells (MSC) having the ability to differentiate into bone, cartilage, adipocytes, nerve cells or skeletal muscle and the like are known to be examples of cells obtained from the adult body that have the ability to differentiate (Non-Patent Documents 7 and 8), these constitute a cell population that includes various cells, the actual state of that differentiation ability is not fully understood, and there have been considerable variations in the therapeutic effects thereof.

In addition, although iPS cells have been reported to be adult-derived pluripotent stem cells (as reported in Patent Document 1, for example), in addition to the establishment of iPS cells requiring an extremely complex procedure consisting of introducing a specific gene into mesenchymal cells in the form of skin fibroblasts or introducing a specific compound into somatic cells, iPS cells are also highly tumorigenic, thereby resulting in the presence of extremely difficult obstacles to their clinical application.

However, there have yet to be any examples describing the use of Muse cells for the prevention and / or treatment of skin ulcer that clearly demonstrate the obtaining of anticipated therapeutic effects.

Images